AVROBIO Total Current Liabilities 2011-2026 | AVRO

Annual Total Current Liabilities AVROBIO

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.35 M	13.1 M	19.4 M	16.6 M	14 M	10.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
19.4 M	6.35 M	13.3 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Alector ALEC	69.5 M	$ 2.19	-9.77 %	$ 226 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Cabaletta Bio CABA	16 M	$ 3.34	0.45 %	$ 3.9 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	5.91 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Codexis CDXS	23.6 M	$ 1.02	1.49 %	$ 74.9 M	USA
AbCellera Biologics ABCL	64.3 M	$ 3.74	3.6 %	$ 1.12 B	Canada
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Cerus Corporation CERS	63.6 M	$ 2.6	1.37 %	$ 480 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
CNS Pharmaceuticals CNSP	2.52 M	$ 3.23	2.22 %	$ 1.23 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Collegium Pharmaceutical COLL	440 M	$ 41.75	0.19 %	$ 1.32 B	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Corcept Therapeutics Incorporated CORT	166 M	$ 36.14	1.23 %	$ 3.75 B	USA
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Amarin Corporation plc AMRN	259 M	$ 13.98	1.27 %	$ 5.7 B	Irlanda
Aileron Therapeutics ALRN	5.75 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Catalyst Pharmaceuticals CPRX	147 M	$ 23.77	2.99 %	$ 2.91 B	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Corbus Pharmaceuticals Holdings CRBP	31.9 M	$ 8.41	-1.87 %	$ 36.4 M	USA
Cardiff Oncology CRDF	16.4 M	$ 1.94	0.01 %	$ 130 M	USA
Curis CRIS	19 M	$ 1.1	-3.51 %	$ 6.94 M	USA
CorMedix CRMD	11.4 M	$ 7.16	0.42 %	$ 364 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
Champions Oncology CSBR	23.9 M	$ 6.14	3.89 %	$ 83.9 M	USA
Aravive ARAV	22.1 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	4.46 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Citius Pharmaceuticals CTXR	35.8 M	$ 0.72	-2.34 %	$ 4.84 M	USA
Athira Pharma ATHA	13.1 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	36.9 M	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	10.5 M	$ 4.21	-2.32 %	$ 299 M	USA
CEL-SCI Corporation CVM	4.62 M	$ 3.88	-8.92 %	$ 247 M	USA